2 Multi-lobe bronchoscopy reveals ETI's effects on regional lung infection and inflammation
Durfey, S., Kapnadak, S., Teresi, M., Gambol, T., Willmering, M., Godwin, J., Boyken, L., Stroik, M., Singh, S., Steele, C., Esther, C., Woods, J., Stoltz, D., Pena, T., Clancy, J., Aitken, M., Singh, P.
Published in Journal of cystic fibrosis (01.09.2024)
Published in Journal of cystic fibrosis (01.09.2024)
Get full text
Journal Article
57 Bronchoscopy sampling finds that intra-lung bacterial migration contributes to persistent Pseudomonas aeruginosa infection after elexacaftor-tezacaftor-ivacaftor
Durfey, S., Kapnadak, S., Radey, M., Teresi, M., Gambol, T., Hayden, H., Willmering, M., Godwin, J., Boyken, L., Stroik, M., Singh, S., Steele, C., Woods, J., Vo, A., Stoltz, D., Pena, T., Clancy, J., Aitken, M., Feder, A., Singh, P.
Published in Journal of cystic fibrosis (01.10.2023)
Published in Journal of cystic fibrosis (01.10.2023)
Get full text
Journal Article
EPS6.04 Elexacaftor/tezacaftor/ivacaftor (ETI) reduces sputum pathogen density and lung inflammation, but infection and inflammation persist
Singh, P., Nichols, D., Drufey, S., Kapnadak, S., Pena, T., Steele, C., Teresi, M., Gambol, T., Stoltz, D., Rowe, S., Clancy, J.P., Heltshe, S., Jorth, P., Aitken, M., Morgan, S.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
WS13.06 Regional bronchoscopy sampling indicates that Pseudomonas aeruginosa infections persist throughout the lung after elexacaftor/tezacaftor/ivacaftor (ETI) due to intra-lung bacterial migration
Durfey, S.L., Kapnadak, S.G., Teresi, M., Gambol, T., Radey, M.C., Hayden, H.S., Willmering, M.M., Godwin, J.D., Boyken, L., Stroik, M., Vo, A., Singh, S.B., Steele, C., Woods, J.C., Stoltz, D., Pena, T., Clancy, J.P., Aitken, M.L., Feder, A.F., Singh, P.K.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
564 Regional lung sampling after elexacaftor/tezacaftor/ivacaftor reveals Pseudomonas aeruginosa persistence in high- and low-damage segments
Durfey, S., Kapnadak, S., Godwin, J., Gambol, T., Teresi, M., Willmering, M., Boyken, L., Stroik, M., Vo, A., McGeer, K., Woods, J., Stoltz, D., Pena, T., Clancy, J., Aitken, M., Singh, P.
Published in Journal of cystic fibrosis (01.10.2022)
Published in Journal of cystic fibrosis (01.10.2022)
Get full text
Journal Article